Breakthrough T1D NorCal August 2026 Newsletter
Sana’s Gene-Edited Islets Continue to Make Insulin Sana Biotechnology’s novel cell therapy approach uses gene editing to help transplanted islet…
Breakthrough T1D NorCal July 2026 Newsletter
Tzield Approved for Stage 3 T1D in the U.S. In an exciting update for the type 1 diabetes (T1D) community,…
Breakthrough T1D NorCal June 2026 Newsletter
The Breakthrough T1D NorCal Community Games Returns to Da Boccery in Livermore on September 27 Join us on Sunday, September…
Breakthrough T1D NorCal May 2026 Newsletter
Meet Our Speakers for the 2026 Breakthrough T1D Community Summit: NorCal We’re excited to announce the distinguished speakers joining us…
Breakthrough T1D NorCal April 2026 Newsletter
National Volunteer Week is April 19-25 During this week, we will be celebrating the remarkable dedication of our volunteers. This…
Breakthrough T1D NorCal March 2026 Newsletter
Spotlight on OPF-310: A Porcine-Derived Cell Therapy in Clinical Trials One of our most promising avenues toward cures for…
Breakthrough T1D NorCal February 2026 Newsletter
Smart devices, angry skin: The underside of diabetes tech Over the last decade, more people have been using wearable devices,…
Breakthrough T1D NorCal January 2026 Newsletter
2025 Top T1D Advances: Full Speed Ahead As we begin the new year, we look back at 2025 and the…
Breakthrough T1D NorCal December 2025 Newsletter
Demystifying the pipeline of T1D therapies and devices: Turning ideas into reality Every new medical device, therapy, treatment, and…
Breakthrough T1D NorCal Chapter November 2025 Newsletter
November is National Diabetes Awareness Month November is National Diabetes Awareness Month, a time to shine a light on type…